1[1]Sakagashira S, Sanke T, Hanabusa T, et al. Missense mutation of Amylin gene (S20G) in Japanese NIDDM patients. Diabets,1996,45:1279-1281.
2[2]Chuang LM, Lee KC, Huang CN, et al. Role of S20G mutation of Amylin gene in insulin secretion, insulin sensitivity, and typeⅡ diabetes mellitus in Taiwan Residents patients. Diabetologia,1998,41:1250-1251.
3[3]Yamada K, Yuan X, Ishiyama S,et al. Glucose tolerance in Japanese subjects with S20G mutation of the Amylin gene. Diabetologia,1998,41:125-1225.
4[4]Birch CL, Fagan LJ, Armstrong MJ, et al. The S20G islet-associated polypeptide gene mutation in familial NIDDM. Diabetologia,1997,40:1113-1114.
5[5]Nishi M, Aanke T, Seino S, et al. Human islet amyloid polypeptide gene: complete nucleotide sequence chromosomal localization and evolutionary history. Mol Endorinol,1989,3:1775-1779.
6[6]Rushing PA, Hagan MM, Seeley RJ, et al. Amylin: a novel action in the brain to reduce body weight. Endocrinology, 2000, 141:850-853.
7[7]Gebre-Medhin S, Mulder H, Pekny M. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide(Amylin). Biochem Biophys Res Commun, 1998, 250:271-275.
